---
title: "Haisco and Nuvectis sign licensing deal for two drugs"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/290680013.md"
description: "A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser."
datetime: "2026-06-24T08:10:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/290680013.md)
  - [en](https://longbridge.com/en/news/290680013.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/290680013.md)
generator: "portal-rs"
---

# Haisco and Nuvectis sign licensing deal for two drugs

A required part of this site couldn’t load. This may be due to a browser extension, network issues, or browser settings. Please check your connection, disable any ad blockers, or try using a different browser.

### Related Stocks

- [NVCT.US](https://longbridge.com/en/quote/NVCT.US.md)
- [002653.CN](https://longbridge.com/en/quote/002653.CN.md)

## Related News & Research

- [Nuvectis Pharma, Inc. (NASDAQ:NVCT) Given Consensus Recommendation of "Moderate Buy" by Analysts](https://longbridge.com/en/news/298036452.md)
- [Nuvectis Pharma to present at H.C. Wainwright annual investment conference](https://longbridge.com/en/news/297909736.md)
- [Nu Holdings (NU) Could Be 36% Undervalued On Q1 Revenue Beat](https://longbridge.com/en/news/297678277.md)
- [Nu E Power Q2 FY26 net loss more than quadruples to $1.41 million; revenue stays at no revenue](https://longbridge.com/en/news/297517783.md)
- [Nu Holdings Announces Investor Day for December 8, 2026 | NU Stock News](https://longbridge.com/en/news/297833769.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**